Europe — EMA

Oxaliplatin Vianex

Oxaliplatin, the active ingredient in Oxaliplatin Vianex, is a platinum-based antineoplastic agent presented as a strength/form for intravenous use.

Oxaliplatin

Request sourcing

Pack/s

What is Oxaliplatin?

Oxaliplatin, the active ingredient in Oxaliplatin Vianex, is a platinum-based antineoplastic agent presented as a strength/form for intravenous use. It treats colorectal cancer and other gastrointestinal malignancies in adult patients. GNH USA supplies Oxaliplatin Vianex as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres worldwide.

GNH USA supplies Oxaliplatin Vianex as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres worldwide.

What is Oxaliplatin used for?

Oxaliplatin Vianex is a platinum‑based chemotherapy that acts on the colorectal cancer treatment pathway.

- Colorectal cancer: improves survival when combined with fluorouracil and leucovorin. - Gastric cancer: used in combination regimens for advanced disease. - Pancreatic cancer: contributes to tumor response in multi‑drug protocols. - Ovarian cancer: added to standard regimens for refractory cases. - Esophageal cancer: used off‑label in some combination protocols. - Peritoneal carcinomatosis : enh y

What are the side effects of Oxaliplatin?

Oxaliplatin Vianex may

Common : - t ... t ...

What precautions apply to Oxaliplatin?

...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →